2m 2m 2m 2m 2m 2m 2m
NUVATION BIO-A (NUVB)
NYSE
$6.03+$0.27 (+4.60%)
Price as of Jun 23, 2026 7:10 PM EDT- $2.0BMarket Cap
- 183.74%1-Year Change
- BiotechnologyIndustry
NUVATION BIO-A (NUVB)
$6.03+$0.27 (+4.60%)
NUVB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.76 | ||
Change | +$0.20 (+3.60%) | ||
Open | $5.64 | ||
High | $5.88 | ||
Low | $5.61 | ||
Previous Close | $5.56 | ||
Volume | 4,159,283 | ||
30-Day Average Volume | 4,483,299 | ||
1-Week Change | 12.06% | ||
1-Month Change | 22.03% | ||
1-Year Change | 183.74% | ||
3-Year Change | 229.14% | ||
5-Year Change | -40.00% | ||
Fundamentals | |||
Shares Outstanding | 347.2M | ||
Total Assets | $610.2M | ||
Market Cap | $2.0B | ||
Enterprise Value | $1.9B | ||
Period: QTR TTM FY | |||
Revenue | $18.5M | ||
Net Income | $5.4M | ||
Free Cash Flow | $5.0M | ||
EBIT | $10.5M | ||
EBITDA | $11.0M | ||
Net Working Capital | $512.0M | ||
EPS | $0.01 | ||
Enterprise Value/EBITDA | 175 | ||
Enterprise Value/Revenue | 104 | ||
P/B | 6 | ||
P/E | 576 | ||
PEG | 6 | ||
Price/Free Cash Flow | 398 | ||
Price/Operating Cash Flow | 395 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue